Top Analyst Upgrades and Downgrades: Carbonite, Coach, Credit Suisse, DaVita, Intuit, Pandora, ONEOK, Regeneron and More
Stocks may have listed sideways for much of last week, but major indexes were indicated to open higher on Monday. The bull market is now well over eight years old, and equity investors keep proving that they will buy into any major pullback or sell-off of any size. Those same investors continue to look for new investing and trading ideas for income and gains ahead.
24/7 Wall St. reviews dozens of analyst research reports each morning of the week. Our goal is to find new investing and trading ideas for our readers. Some of the daily analyst reports cover stocks to buy. Other reports from the analyst community cover stocks to sell or to avoid.
Consensus analyst price target data are from the Thomson Reuters sell-side research service. Additional color and commentary has also been added on most of the daily analyst calls.
These were the top analyst upgrades, downgrades and other research calls from Monday, June 26, 2017.
Carbonite Inc. (NASDAQ: CARB) was started with an Equal Weight rating and assigned a $25 price target (versus a $24.30 prior close) at Barclays. Carbonite has a 52-week trading range of $8.81 to $24.60 and has a consensus analyst price target of $25.80.
Coach Inc. (NYSE: COH) was raised to Buy from Neutral with a $58 price target (versus a $46.71 close) at Buckingham Research. Coach has a 52-week range of $34.07 to $47.30 and a consensus price target of $49.56.
Credit Suisse Group A.G. (NYSE: CS) was started with an Overweight rating at JPMorgan. Credit Suisse closed at $13.74 on Friday in New York trading, in a 52-week range of $10.01 to $16.17 and with a consensus price target of $17.09.
DaVita Inc. (NYSE: DVA) was downgraded to Hold from Buy with a $70 price target (versus a $64.89 close) at Jefferies. It has a consensus target price of $67.88 and has a 52-week range of $54.50 to $78.77. DaVita still counts Warren Buffett’s Berkshire Hathaway as a 19% or so stakeholder, its largest single shareholder.
Intuit Inc. (NASDAQ: INTU) was downgraded to Neutral from Buy with a $141 price target (versus a $140.40 close) at Citigroup. Intuit has a 52-week range of $103.03 to $143.81 and a consensus price target of $131.94.
Pandora Media Inc. (NYSE: P) was raised to Sector Weight from Underperform at Pacific Crest. Pandora previously closed at $8.28, and it has a 52-week range of $6.76 to $14.98. Shares were indicated higher on Monday on news that CEO Tim Westergren plans to step down from Pandora.
Other key analyst calls were in the following:
Agios Pharmaceuticals Inc. (NASDAQ: AGIO) was downgraded to Neutral from Buy at Janney.
Berry Global Group Inc. (NYSE: BERY) was raised to Buy from Hold with a $65 price target (versus a $57.04 close) at SunTrust Robinson Humphrey.
Cidara Therapeutics Inc. (NASDAQ: CDTX) was started with an Overweight rating and assigned a $15 price target (versus a $6.70 close) at Cantor Fitzgerald. Cidara fell 2.9% on Friday, and its 52-week range is $5.65 to $12.95. The consensus target price was $13.39 coming into this call.
Cancer Genetics Inc. (NASDAQ: CGIX) was started with a Buy rating and assigned a $6 price target (versus a $3.85 close) at Benchmark. This matches the consensus target price, but that is from a tiny pool of analysts.
Janus Henderson Group PLC (NYSE: JHG) was started with a Neutral rating and assigned a $33 price target (versus a $32.90 close) at Goldman Sachs.
LyondellBasell Industries N.V. (NYSE: LYB) was started with a Buy rating and assigned a $101 price target (versus $80.17 close) at HSBC.
ONEOK Inc. (NYSE: OKE) was started with a Hold rating and assigned a $48 price target at Stifel.
PPL Corp. (NYSE: PPL) was raised to Neutral from Sell at Goldman Sachs.
PRA Health Services Inc. (NASDAQ: PRAH) was started with a Buy rating and assigned an $89 price objective (versus a $75.38 close) at Merrill Lynch.
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) was downgraded to Market Perform from Outperform with a $480 price target (versus a $517.33 close) at Sanford Bernstein. Regeneron has a 52-week range of $325.35 to $543.55.
Rice Energy Inc. (NYSE: RICE) was downgraded to Sector Perform from Outperform with a $27 price target (versus a $25.65 close) at Scotia Capital.
Visteon Corp. (NYSE: VC) was raised to Outperform from Market Perform with a $115 price target (versus a $95.91 close) at BMO Capital Markets.
Friday’s top analyst calls included AK Steel, Altice USA, Biogen, Caterpillar, Gilead, Oracle and about a dozen more.
Also check out seven recent analyst stock picks that could rise 100% or much more.
You can follow @Jonogg on Twitter if you want the daily analyst calls and other research notes directly on your feed.